Exane Derivatives’s Black Knight, Inc. Common Stock BKI Stock Holding History

Exane Derivatives’s Portfolio BKI Stock Details BKI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$65	Hold	1	–	–	﹤0.01%	735
2022 Q1	$58	Hold	1	–	–	﹤0.01%	999
2021 Q4	$83	Sell	1 -644	-100%	-$48.1K	﹤0.01%	862
2021 Q3	$46.4K	Sell	645 -131	-17%	-$10.1K	0.01%	623
2021 Q2	$61.3K	Sell	776 -2,237	-74%	-$165K	0.01%	620
2021 Q1	$223K	Buy	3,013 +582	+24%	+$46.8K	0.06%	283
2020 Q4	$215K	Buy	2,431 +1,441	+146%	+$131K	0.06%	303
2020 Q3	$86.2K	Buy	+990	New	+$78K	0.03%	325

Other funds holding BKI

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ACM

Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LCOV

London Company of Virginia Richmond, Virginia $17.5B AUM 29.92% 1-Year Est. Return

Exane Derivatives's BKI Position: Q2 2022 in Review

Exane Derivatives held its Black Knight, Inc. Common Stock (BKI) position steady in Q2 2022 at 1 share worth $65. The position accounts for ﹤0.01% of the portfolio, ranked #735.

Exane Derivatives first reported a position in BKI in Q3 2020 and has held it in 8 quarters since. The position peaked at $223K in Q1 2021. 445 funds tracked by Wall St. Rank hold BKI as of Q2 2022.

Exane Derivatives held 1 share of Black Knight, Inc. Common Stock worth $65 as of Q2 2022.
Exane Derivatives left its Black Knight, Inc. Common Stock share count unchanged in Q2 2022.
Black Knight, Inc. Common Stock made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #735 holding.
Exane Derivatives first reported a position in Black Knight, Inc. Common Stock in Q3 2020 and has held it in 8 quarters since.
Exane Derivatives's Black Knight, Inc. Common Stock position peaked at $223K in Q1 2021.
445 funds tracked by Wall St. Rank held Black Knight, Inc. Common Stock as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.